Cardiff Oncology to Present at Sidoti’s Year-End Virtual Investor Conference
(NASDAQ:CRDF), SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will present and host one-on-one meetings at Sidoti's Year-End Virtual Investor Conference, which is taking place from December 10-11, 2025. […]